At the completion of this activity, the participant will be able to:
1. Describe the current place in therapy for SGLT2 inhibitors
2. Review primary literature supporting SGLT2 inhibitor use in cardiovascular disease
3. Discuss the proposed hypotheses for pleiotropic effects of SGLT2 inhibitors
4. Review primary literature supporting SGLT2 inhibitor use for nephro-protective benefits
5. Discuss the clinical pearls of SGLT2 inhibitor use in practice

Session date: 
Wednesday, October 21, 2020 - 12:00pm to 1:00pm
Location: 
AGH Magovern Auditorium and Zoom
https://zoom.us/j/92807709160
Meeting ID: 928 0770 9160 Passcode: 902570
Pittsburgh, PA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.